Critical cytokine pathways to cardiac inflammation

Journal of Interferon and Cytokine Research

Volumn 31, Issue 10, 2011, Pages 705-710

  Rose, Noel R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNE MYOCARDITIS; AUTOIMMUNITY; CELLULAR IMMUNITY; COXSACKIE VIRUS; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; EOSINOPHIL; HEART FAILURE; IMMUNOPATHOLOGY; INNATE IMMUNITY; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH2 CELL; VIRUS IMMUNITY;

ANIMALS; AUTOIMMUNE DISEASES; COXSACKIEVIRUS INFECTIONS; CYTOKINES; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; HUMANS; IMMUNITY, INNATE; MICE; MYOCARDITIS; MYOCARDIUM; T-LYMPHOCYTES, HELPER-INDUCER;

COXSACKIEVIRUS;

EID: 80054679259     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0057     Document Type: Review

References (36)

1. Afanasyeva M, Rose NR. 2002. Immune mediators in inflammatory heart disease: insights from a mouse model. Eur Heart J 4 (Suppl. 1):131-136.
2. Afanasyeva M, Rose NR. 2004. Viral infection and heart disease: autoimmune mechanisms. In: Shoenfeld Y, Rose NR, eds. Infection and Autoimmunity. Amsterdam: Elsevier. pp 299-318.
3. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR. 2001a. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 159:193-203. (Pubitemid 33704204)
4. Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, Rose NR. 2001b. Interleukin-12 recepter/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-independent pathway. Circulation 104:3145-3151. (Pubitemid 34014072)
5. Baldeviano GC, Barin JC, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D. 2010. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106:1646-1655.
6. 3 induced myocarditis among H-2 congenic mouse strains. In: Skamene E, ed. Genetic control of resistance to infection and malignancy, (Prog Leuko Biol, Vol. 3) New York: Alan R. Liss, Inc. pp 195-201.
7. Cihakova D, Barin JG, Afanasyeva M, Kimura M, Fairweather D, Berg M, Talor MV, Baldeviano GC, Frisancho S, Gabrielson K, Bedja D, Rose NR. 2008. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macro-phage differentiation. Am J of Pathol 172(5):1195-1208. (Pubitemid 351671534)
8. Cihakova D, Rose NR. 2008. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv in Immunol 99:95-114.
9. Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR. 2004. Mast cells and innate cytokines areassociated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection. Autoimmunity 37: 131-145. (Pubitemid 38594277)
10. Fairweather D, Frisancho-Kiss S, Rose NR. 2005a. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 15:17-27. (Pubitemid 40070040)
11. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJL, Rose NR. 2005b. IL-12 protects against Coxsackievirus B3-induced myocarditis by increasing IFN-g and macrophage and neutrophil populations in the heart. J Immunol 174:261-269. (Pubitemid 40007412)
12. Fairweather D, Rose NR. 2004. Models of Coxsackievirus-B3-induced myocarditis: recent advances. Drug Discov Today: Dis Models 1:381-386. (Pubitemid 41123746)
13. Fairweather DL, Rose NR. 2005. Inflammatory heart disease: a role for cytokines. Lupus 14:646-651. (Pubitemid 41413283)
14. Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N. 2010. Proin-flammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15:543-562.
15. 3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol 9:1311-1319. (Pubitemid 17083530)
16. Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, Rose NR. 2002. Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol 168:1552-1556. (Pubitemid 34135748)
17. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. 1991. LPS promotes CB3-induced myocarditis in resistant B10.A mice. Cell Immunol 136:219-233.
18. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. 1992. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med 175:1123-1129.
19. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. 1993. Role of IL-1 and tumor necrosis factor in Coxsackie virus-induced autoimmune myocarditis. J Immunol 151: 1682-1690. (Pubitemid 23219307)
20. 3-induced myocarditis. J Immunol 138:2488-2492. (Pubitemid 17051821)
21. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. 1987b. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139:3630-3636. (Pubitemid 18013633)
22. Neumann DA, Lane JR, Allen GS, Herskowitz A, Rose NR. 1993. Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis? Clin Immunol Immunopathol 68:181-190. (Pubitemid 23278071)
23. Rose NR. 2000. Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat Med 6:5-6.
24. Rose NR. 2001. Infection, mimics and autoimmune disease. J Clin Invest 107:943-944.
25. Rose NR. 2009. Myocarditis: infection versus autoimmunity. J Clin Immunol 29:730-737.
26. Rose NR, Afanasyeva M. 2003a. From infection to autoimmu-nity: the adjuvant effect. ASM News 69:132-137.
27. Rose NR, Afanasyeva M. 2003b. The inflammatory process in experimental myocarditis. In: Feuerstein GZ, Libby P, Mann DL, eds. Inflammation and heart disease. Basel: Birkhäuser Verlag. pp 325-333.
28. Rose NR, Beisel KW, Herskowitz A, Neu N, Wolfgram LJ, Alvarez FL, Traystman MD, Craig SW. 1987. Cardiac myosin and autoimmune myocarditis. In: Evered D, Whelan J, eds. Autoimmunity and autoimmune disease. Ciba Foundation Symposium 129. Chichester, UK: John Wiley & Sons, Ltd. pp 3-24.
29. Rose NR, Herskowitz A, Neumann DA, Neu N. 1988a. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today 9:117-119.
30. Rose NR, Hill SL. 1996. Autoimmune myocarditis. Int J Cardiol 54:171-175. (Pubitemid 26189011)
31. Rose NR, Mackay IR. 2000. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 57:542-551. (Pubitemid 30311425)
32. Rose NR, Neumann DA, Herskowitz A, Traystman MD, Beisel KW. 1988b. Genetics of susceptibility to viral myocarditis in mice. Pathol Immunopathol Res 7:266-278.
33. 3-induced myocarditis. Ann N Y Acad Sci 475:146-156. (Pubitemid 16040505)
34. Wang Y, Afanasyeva M, Hill SL, Rose NR. 2000. Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice. J Am Coll Cardiol 36:1992-1999.
35. 3 myocarditis. J Exp Med 161:1112-1121. (Pubitemid 15011328)
36. Wolfgram LJ, Rose NR. 1989. Coxsackievirus infection as a trigger of cardiac autoimmunity. Immunol Res 8:61-80. (Pubitemid 19055594)